Abstract # 2446 Biomab Egfrtm (nimotuzumab/h-r3) in Combination with Standard of Care in Squamous Cell Carcinoma of Head and Neck (scchn)

Presenter: Reddy, Bayyagari

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

B. K. Reddy*1, M. Vidyasagar*2, K. Shenoy*3, A. Shenoy*1, L. Viswanath*1, G. Babu*1, P. Bapsy*1, M. Sathya*1, M. Srivastava*4, -. Nanjundappa*1. , 1Kidwai Memorial Institute of Oncology, Bangalore, India, 2Shirdi Sai Baba Cancer Hospital, Manipal, India,

Author Disclosure:
 B.K. Reddy, None; M. Vidyasagar, None; K. Shenoy, None; A. Shenoy, None; L. Viswanath, None; G. Babu, None; P. Bapsy, None; M. Sathya, None; M. Srivastava, None; -. Nanjundappa, None.

E-mail a friend about this abstract:
Enter email address: